CSIMarket
 
Tela Bio Inc   (TELA)
Other Ticker:  
 
 
Price: $5.3300 $-0.08 -1.479%
Day's High: $5.5399 Week Perf: -3.44 %
Day's Low: $ 5.24 30 Day Perf: -26.07 %
Volume (M): 223 52 Wk High: $ 11.65
Volume (M$): $ 1,186 52 Wk Avg: $8.17
Open: $5.37 52 Wk Low: $4.23



 Market Capitalization (Millions $) 131
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) 51
 Net Income (TTM) (Millions $) -44
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 1

Tela Bio Inc
Tela Bio Inc is a medical technology company that specializes in the development and commercialization of tissue engineering products for surgical reconstruction of soft tissue defects. The company focuses on creating advanced and innovative products that improve patient outcomes and surgical techniques. Tela Bio's products are made from a proprietary material called OviTex, which combines biologic and synthetic components to optimize integration, strength, and compatibility with the body. The company's solutions are used in various surgical procedures, including hernia repair, abdominal wall reconstruction, and plastic/reconstructive surgery. Tela Bio Inc aims to provide surgeons with advanced tools to deliver better patient care and improve the quality of life for surgical patients.


   Company Address: 1 Great Valley Parkway, Suite 24 Malvern 19355 PA
   Company Phone Number: 320-2930   Stock Exchange / Ticker: NASDAQ TELA
   TELA is expected to report next financial results on March 21, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Management Announcement

TELA Bio Grants Restricted Stock Units to New Hires, Aims to Overcome Financial Challenges

Published Fri, Feb 23 2024 9:05 PM UTC

TELA Bio Approves Inducement Grants for New Employees Under Nasdaq Rule 5635(c)(4)
TELA Bio, Inc. (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction solutions, has recently announced that it has approved inducement grants for five newly-hired employees. The Compensation Committee of the Board of Directors of TELA Bio granted restrict...

Financing Agreement

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Foster Talent Acquisition and Drive Innovation

Published Fri, Jan 19 2024 9:05 PM UTC

TELA Bio, Inc. (?TELA Bio?), a leading medical technology company committed to revolutionizing soft-tissue reconstruction solutions that prioritize the preservation and restoration of patients' own anatomy, disclosed today the approval of inducement grants by the Compensation Committee of its Board of Directors. These restricted stock units, amounting to 5,500 shares of TELA...

Financing Agreement

TELA Bio Empowers New Hires with Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Drive Innovation and Optimize Patient Outcomes

Published Fri, Dec 15 2023 9:05 PM UTC


Introduction
TELA Bio, a leading medical technology company specializing in soft-tissue reconstruction solutions, has recently announced its approval of inducement grants in the form of restricted stock units (RSUs). These grants, covering a total of 20,175 shares of common stock, have been offered to sixteen newly-hired employees and were deemed necessary to encour...

Tela Bio Inc

Tela Bio Inc's Financial Third Quarter of 2023 Witnesses an Impressive Feat



Tela Bio Inc has recently released its financial results for the fiscal interval ending September 30, 2023. Despite facing challenges in its stock performance, the company has showcased promising improvements in various aspects of its business. Let's examine these results in the context of the company's financial performance.
Improved Earnings Per Share:
Tela Bio Inc's earnings per share (EPS) for the fiscal period ending September 2023 decreased to -$0.45 compared to -$0.64 per share in the same period a year ago. Additionally, the EPS improved from -$0.46 per share in the previous quarter. This signals a positive development for the company, indicating a potential turnaround in profitability.

Shares

TELA Bio's Inducement Grants Signal Commitment to Talent Acquisition as Share Price Continues to Fumble in 2023

Published Fri, Nov 10 2023 9:05 PM UTC


TELA Bio's Inducement Grants:
TELA Bio has authorized the issuance of restricted stock units covering 40,700 shares of its common stock to thirty-one newly-hired employees. The grants were deemed necessary as inducement material to secure the acceptance of employment with TELA Bio. These grants were approved in compliance with the Nasdaq Rule 5635(c)(4) inducement g...






 

Tela Bio Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com